Evolving together · Directed co-evolution via engineered cell-to-cell communication
„Хоризонт 2020“ — Действия „Мария Склодовска-Кюри“
- Период
- 2021-05-01 → 2023-04-30
- Финансиране от ЕС
- 212 934 €
- Участници
- 1
- Схема
- MSCA-IF
Линиите свързват координатора с партньорите.
Накратко на български
Екипът разработва метод за едновременна еволюция на два протеина, като за пример използва двойка антиген-антитяло в пекарска мая. Това помага за по-доброто разбиране на клетъчната комуникация, диференциацията и процесите по поправка на ДНК.
Кратко обяснение, генерирано от езиков модел по текста на CORDIS. Оригиналът е по-долу.
Резултати накратко
Directed co-evolution via engineered cell-to-cell communication
Evolving Together aims to tackle one of the current challenges in biotechnology which consists of the co-evolution of two target molecules and to study DNA repair. Directed evolution is a method in protein engineering that mimics the Darwinian evolution in the lab. The importance of this technique was recognized with the Nobel price in Chemistry in 2018, and has been used to evolve hundres of proteins with different applications, and has revolutionized very different fields from neuroscience, to chemical catalysis, with special relevance in main biotechnological processes. In directed evolution, the genetic variability is induced or created artificially, and the library is subject to a biochemical assay where the desired physicochemical properties of the enzyme are harnessed for its enrichment from the rest of the pool. This process normally is iterated several times until a bigger percentage of the population displays the desired evolved features. Traditionally, directed evolution targets one single protein at a time. In evolving together, we plan to co-evolve simultaneous two different proteins. To showcase this new approach, we have selected a low-affinity antigen-antibody pair, which is going to be displayed at the surface of the yeast strain Saccharomyces cerevisiae (Sc), also known as Baker’s yeast. The development of a platform for the co-evolution of two different proteins simultaneously and a reporter system to study DNA repair in yeast will be highly desirable for many reasons. The development of this platform shed some light on other more biologically relevant processes such as cellular communication and differentiation. Moreover, antibody engineering and maturation have been the focus of many biotechnological companies, and the development of this platform will have immediate applications. Finally, the design of a genetic system that enables to visualize in a quantitive manner the different DNA-repair mechanisms will be ideal to establish new screening assays for drugs that affect the DNA repair machinery. This area of research has been propelled in the last years by the increase in research on genome engineering and editing.
Текст от CORDIS, на английски · Данни: CORDIS, © Европейски съюз
Цел на проекта
The aim of this Marie Skłodowska-Curie Fellowship (Evolving Together) is to develop an innovative new system for directed co-evolution of ligand-receptor pairs in two different cell populations. This novel cell-to-cell directed evolution platform will facilitate the development of synthetic, orthogonal intercellular signaling pathways that can be applied to control and manipulate cells by user-defined expression of a target gene. The selection of the reporter gene can be extremely flexible, which allows full customization of the downstream cellular response, such as programming self-organized cellular patterns or targeting specific cell populations. This Fellowship will be undertaken under the supervision of Prof. Tom Ellis (Imperial College London Centre for Synthetic Biology), who is internationally renowned in synthetic biology and is leading the UK’s effort in the Synthetic Yeast Genome Project (Sc2.0), one of the world’s largest synthetic biology projects to date. My proposed research brings together many aspects of synthetic biology and molecular biology techniques, including molecular cloning, cell culture, protein and genome engineering, directed evolution, and next generation sequencing (NGS). In addition, we will extensively use fluorescence-activated cell sorting (FACS) and confocal imaging to isolate and characterize the populations of interest. These techniques combine skills I’ve acquired during previous research along with the expertise and methods of Tom Ellis’ group. Evolving Together presents an opportunity to make a major new innovation in directed evolution that can impact various fields of biology and biomedicine such as signaling, protein engineering, biomaterials, synthetic biology and therapeutics.
Оригинален текст от CORDIS (на английски).
Участници
- IMPERIAL COLLEGE OF SCIENCE TECHNOLOGY AND MEDICINE · LondonКоординаторОбединеното кралство
Връзки
Данни: CORDIS, © Европейски съюз
